Search research articles
Contact Us
Filters
Showing results (101-110 of 387) with videos related to
Page
of 39
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 20, 2004
Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UK
A Shearer, A Bagust, D Sanderson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
November 10, 2004
Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis
Ralph D Sanderson, Yang Yang, Larry J Suva, et al.
European Journal of Gastroenterology & Hepatology
|
June 1, 2012
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis
Lennard Y W Lee, Jeremy D Sanderson, Peter M Irving
American Journal of Clinical Pathology
|
September 9, 1999
Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma
M J Stanley, M W Stanley, R D Sanderson, et al.
Cancer Research
|
March 1, 1984
Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells
I B Glowinski, N D Sanderson, S Hayashi, et al.
The Journal of Laryngology and Otology
|
April 1, 1996
Speech assessment of patients using three types of indwelling tracheo-oesophageal voice prostheses
J M Heaton, D Sanderson, I R Dunsmore, et al.
Scandinavian Journal of Gastroenterology
|
December 23, 2003
A prospective study of the technical feasibility of ileoscopy at colonoscopy
A Ansari, S Y Soon, B P Saunders, et al.
Blood
|
September 26, 2000
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins
M Børset, O Hjertner, S Yaccoby, et al.
Current Medicinal Chemistry
|
April 3, 2001
Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations
S M Taylor, S A Sherman, L Kirnarsky, et al.
Journal of Periodontal Research
|
August 10, 2000
C5a modulation of interleukin-1 beta-induced interleukin-6 production by human osteoblast-like cells
J M Pobanz, R A Reinhardt, S Koka, et al.
Page
of 39
Search research articles
Search
Showing results (101-110 of 387) with videos related to
Sort By:
Page
of 39
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 20, 2004
Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UK
A Shearer, A Bagust, D Sanderson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
November 10, 2004
Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis
Ralph D Sanderson, Yang Yang, Larry J Suva, et al.
European Journal of Gastroenterology & Hepatology
|
June 1, 2012
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis
Lennard Y W Lee, Jeremy D Sanderson, Peter M Irving
American Journal of Clinical Pathology
|
September 9, 1999
Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma
M J Stanley, M W Stanley, R D Sanderson, et al.
Cancer Research
|
March 1, 1984
Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells
I B Glowinski, N D Sanderson, S Hayashi, et al.
The Journal of Laryngology and Otology
|
April 1, 1996
Speech assessment of patients using three types of indwelling tracheo-oesophageal voice prostheses
J M Heaton, D Sanderson, I R Dunsmore, et al.
Scandinavian Journal of Gastroenterology
|
December 23, 2003
A prospective study of the technical feasibility of ileoscopy at colonoscopy
A Ansari, S Y Soon, B P Saunders, et al.
Blood
|
September 26, 2000
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins
M Børset, O Hjertner, S Yaccoby, et al.
Current Medicinal Chemistry
|
April 3, 2001
Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations
S M Taylor, S A Sherman, L Kirnarsky, et al.
Journal of Periodontal Research
|
August 10, 2000
C5a modulation of interleukin-1 beta-induced interleukin-6 production by human osteoblast-like cells
J M Pobanz, R A Reinhardt, S Koka, et al.
Page
of 39